- Home
- SYBX vs AMZE Comparison
SYBX vs AMZE Comparison
Compare SYBX & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYBX | AMZE |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 12.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SYBX | AMZE |
|---|---|---|
| Price | $1.13 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.7K | ★ 44.4M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,245,143.00 |
| Revenue This Year | N/A | $6,741.66 |
| Revenue Next Year | N/A | $100.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 369.95 |
| 52 Week Low | $0.90 | $0.24 |
| 52 Week High | $1.96 | $19.44 |
Technical Indicators
Market Signals| Indicator | SYBX | AMZE |
|---|---|---|
| Relative Strength Index (RSI) | 20.66 | 34.05 |
| Support Level | $1.58 | $0.39 |
| Resistance Level | $1.73 | $0.63 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 7.58 | 39.22 |
Price Performance
Historical ComparisonAbout SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.